• How Life Sciences Companies are Solving the Organ Transplant Crisis

    14 days ago

    Our modern way of life is the cause and the cure to the organ transplantation crisis. Technological advancements and increasing wealth have led to a booming population that suffers chronic illness, obesity and old age. These factors contribute to a massive demand for organs that outstrips supply. In the US alone, over 120,000 people are currently on the transplantation waiti...

    Read more
    Shutterstock 1161245233 [Converted]
  • Advancing Women of Color in STEM

    3 months ago

    ​​90% of CEOs report that diversity is a top business priority, yet the dial towards progress has hardly moved in recent years. A quantitative study by MassBio showed that although women make up half of the entry-level positions in biotech, they fill only 20 percent of senior leadership slots and 10 percent of board seats. While a 2017 study of the US biotech industry by Nat...

    Read more
    Epm Spotlight Advancing Women Of Colour In Stem (1200x628)
  • EPM Scientific to Moderate Panel at Biotech Week Boston

    7 months ago

    ​We are delighted to announce Andrew McNeilis, Chief Commercial Officer, will be moderating a panel this year at Boston BD, taking place on September 10th, 2019. This forum convenes C-level executives to discuss the most pressing business development challenges and opportunities facing the biopharma industry. This conference is a part of Biotech Week Boston, a festival of in...

    Read more
    Shutterstock 1335730964
  • Launch or License: Taking Your First Product to Europe

    7 months ago

    ​For many emerging US-based biotech companies, taking their first product to Europe is a daunting prospect. Directly launching abroad is a difficult path, with many companies deciding to out-license rights for that territory instead. While doing so cuts down risk, it typically reduces profits and inhibits the potential to create a global brand and market strategy; companies ...

    Read more
    Launch Or License Article Embedd
  • Overcoming the Founder's Dilemma: Why You Should Recruit Outside Your Network

    8 months ago

    ​Biotech start-ups can be nimble and responsive if they utilize a small, tight-knit, interdisciplinary team. However, the minute work-groups start to expand they are susceptible to the founder’s dilemma. So how can an elite team find the right recruits that will align in terms of their technical skills, experience and vision, as well as their cultural fit? Small teams can be...

    Read more
    Shutterstock 751727689
  • Recruiting for Oncology: Top US Trends for 2019

    9 months ago

    In the last decade, innovations in cell and gene-based therapies have changed the Oncology recruitment market. So what does a top Oncology candidate look like in 2019?In the lead-up to the American Society of Clinical Oncology (ASCO) annual conference, we always take stock of current trends in Oncology recruitment. In 2019 new therapies, like gene editing, are driving the ma...

    Read more
    Epm Article Oncology
  • Best Biometrics Team: In-House or Outsourced?

    9 months ago

    ​Up to 77% of biotech and pharma outsource portions of their analytics or production. There are many reasons to outsource, in source, or stay completely in-house. For biometrics teams, outsourcing can increase standardization while staying in-house decreases turnaround time.Biotech and pharma often debate whether to outsource analytics. Benefits of outsourcing can include re...

    Read more
    Shutterstock 1191637648
  • Why US Biotech Companies Should Consider Launching in Europe Directly

    11 months ago

    ​In the past, biotech startups have sought to partner with big pharmaceutical companies.  However, the market is changing — in 2019 it may be better to license directly in Europe.For a US-based pharmaceutical company, the prospect of taking a new drug to market in Europe can be daunting.  Many young biotech companies decide to out-license for royalty or milestone payments in...

    Read more
    Shutterstock 407960497
  • Bioartificial Kidneys and Tissue Engineering: Cyborg Future?

    about 1 year ago

    ​UCSFs bioartificial kidney is an exciting breakthrough which circumvents the need for tissue-blood supply, using  cyborg-like silicon chips. In this article we explore UCSF’s Kidney Project, the latest applications of tissue engineering, and the recruitment trends within the pharma and biotech fields.We have previously discussed how the fields of tissue-engineering and rege...

    Read more
    Shutterstock 127847810
  • Emerging Markets in Tissue Engineering

    about 1 year ago

    ​Tissue-engineered substrates like Axogen nerve-grafts and 3D-printed hydrogels have penetrated past the hype phase of the Garner hype cycle to the main market.  Tissue-engineering and regenerative medicine are hot topics lately.  While the average person associates these therapies with idealistic sci-fi, the truth is that these therapies have exited controversial trial-and-...

    Read more
    Shutterstock 1338992195
  • A War on Talent: How Medical Communications Agencies are Targeting Top Performers in 2019

    about 1 year ago

    ​Globalization and digitization have changed the world’s economy, and now they are changing health. The biotech and pharma markets make and sell the therapies we use to rejuvenate and repair our bodies. As our technology changes, so does our health, and the potential for human health has never been greater.   So how do we communicate novel therapeutics to life sciences profe...

    Read more
    Shutterstock 751727647
  • Innovation And Implications In CAR-T Therapy

    about 1 year ago

    ​In September 2018 the National Health Service England approved Novartis’ game-changing CAR-T therapy KYMRIAH® (tisagenlecleucel) for the treatment of childhood acute lymphoblastic leukaemia (ALL). So far, CAR-T had only been available to patients in Europe via clinical trials.As documented by Pharma Times this treatment is approved for “patients up to 25 years old with B ce...

    Read more
    Shutterstock 142893724
  • The Bleeding Edge: Where Do We Go From Here?

    over 1 year ago

    ​The Bleeding Edge is a famous documentary that scrutinizes the side effects of implantable devices. Let’s offer an unbiased analysis of the benefits and drawbacks of devices, and discuss how biotech and pharma can do better.   While the public often feels powerless to change large organizations the truth is that pharmaceutical companies are heavily regulated and subject to ...

    Read more
    Shutterstock 707493547
  • Why We Need Better Antibiotics and What Biotech and Pharma Are Doing About It

    over 1 year ago

    ​Antibiotics extended the human lifespan — but now they’re under threat.  Breaking news from three companies this month showcase how big pharma is stepping up to the plate.The average human lifespan has more than doubled since 1900 and this trend is expected to continue. But the biggest leaps in medical history have predominantly been due to advances in infectious disease, s...

    Read more
    Pills
  • Hiring Trends in Gene-Therapy and Gene-Editing Startups

    over 1 year ago

    ​Gene therapy is hot right now.The human genome was sequenced in 2003 for $2.7 billion USD.  In 2018, it costs less than $1,000 to sequence a human genome and this cost is expected to decrease to less than $100 in the near future.  Welcome to the future of precision medicine.According to the National Institutes of Health, precision medicine is treatment “that takes into acco...

    Read more
    Shutterstock 134698571
  • How Big Data Impacts Life Sciences Hiring

    over 1 year ago

    ​Pharma and biotech are digitizing.Historically, natural resources have driven the global economy, what the OECD calls the “real wealth of nations”. However, this wealth-model has changed because for the first time in human history we can measure the details of our life at scale.  What is big data?The term ‘big data’ is used to describe extremely large sets of data that, due...

    Read more
    Shutterstock 537098116
  • Is Remote Working the Missing Ingredient in Your Recruitment Offering?

    almost 2 years ago

    ​What’s the best way to attract and retain top talent in pharma? Increasingly, flexible working is being prioritized by candidates alongside pay, conditions and development opportunities. Employers who enable remote working communicate trust to their employees – and the reward is often a boom in productivity.The increasing shift towards remote workingAccording to the 2017 St...

    Read more
    Shutterstock 1308783484
  • The Rising Demand in the Orthopedic Implant Market

    almost 2 years ago

    ​The orthopedic devices industry is growing fast. By 2020, the sector is expected to rank third in sales, after cardiology and in-vitro diagnostics.[1] It’s an industry that offers rewarding careers, too, with strong demand for individuals who can use cutting-edge technology to improve patients’ lives.Why is the orthopedic implants sector growing?Medical innovation and an ag...

    Read more
    Orthopedic
  • Move Over California – Boston Is Now the World’s No.1 Biotech Hub

    almost 2 years ago

    ​Biotech is booming in Boston. Massachusetts is now the number one biotech hub in the world, overtaking closest rival California. As a recent MassBio report[1] makes clear, biotech industry jobs have grown 28% in the last 10 years – and not by chance. The Boston metropolitan area, including Cambridge, Worcester and Waltham, has been doing all it can to attract the best talen...

    Read more
    Shutterstock 531456361
  • The Candidate Experience and its Role in Successful Hiring

    almost 2 years ago

    ​Are you focused on the candidate experience?What makes the perfect interview process? The right format? The right panel? The right questions? These are all important factors to consider, but none of them are as significant as the candidate experience.So are companies giving the candidate experience the attention it deserves? Ask job seekers what they think and the answer wo...

    Read more
    Shutterstock 1281381391